Cargando…
S165: CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428232/ http://dx.doi.org/10.1097/01.HS9.0000967572.05685.92 |
| _version_ | 1785090417961730048 |
|---|---|
| author | Platzbecker, Uwe Santini, Valeria Fenaux, Pierre Sekeres, Mikkael Savona, Michael Robert Madanat, Yazan Díez Campelo, María Valcárcel, David Illmer, Thomas Jonášová, Anna Belohlavkova, Petra Sherman, Laurie Berry, Tymara Dougherty, Souria Shah, Sheetal Xia, Qi Peng, Lixian Sun, Libo Wan, Ying Huang, Fei Ikin, Annat Navada, Shyamala Komrokji, Rami S. Zeidan, Amer M. |
| author_facet | Platzbecker, Uwe Santini, Valeria Fenaux, Pierre Sekeres, Mikkael Savona, Michael Robert Madanat, Yazan Díez Campelo, María Valcárcel, David Illmer, Thomas Jonášová, Anna Belohlavkova, Petra Sherman, Laurie Berry, Tymara Dougherty, Souria Shah, Sheetal Xia, Qi Peng, Lixian Sun, Libo Wan, Ying Huang, Fei Ikin, Annat Navada, Shyamala Komrokji, Rami S. Zeidan, Amer M. |
| author_sort | Platzbecker, Uwe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428232 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104282322023-08-17 S165: CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3 Platzbecker, Uwe Santini, Valeria Fenaux, Pierre Sekeres, Mikkael Savona, Michael Robert Madanat, Yazan Díez Campelo, María Valcárcel, David Illmer, Thomas Jonášová, Anna Belohlavkova, Petra Sherman, Laurie Berry, Tymara Dougherty, Souria Shah, Sheetal Xia, Qi Peng, Lixian Sun, Libo Wan, Ying Huang, Fei Ikin, Annat Navada, Shyamala Komrokji, Rami S. Zeidan, Amer M. Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428232/ http://dx.doi.org/10.1097/01.HS9.0000967572.05685.92 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Platzbecker, Uwe Santini, Valeria Fenaux, Pierre Sekeres, Mikkael Savona, Michael Robert Madanat, Yazan Díez Campelo, María Valcárcel, David Illmer, Thomas Jonášová, Anna Belohlavkova, Petra Sherman, Laurie Berry, Tymara Dougherty, Souria Shah, Sheetal Xia, Qi Peng, Lixian Sun, Libo Wan, Ying Huang, Fei Ikin, Annat Navada, Shyamala Komrokji, Rami S. Zeidan, Amer M. S165: CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3 |
| title | S165: CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3 |
| title_full | S165: CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3 |
| title_fullStr | S165: CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3 |
| title_full_unstemmed | S165: CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3 |
| title_short | S165: CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3 |
| title_sort | s165: continuous tranfusion independence with imetelstat in heavily transfused non-del(5q) lower-risk myelodysplastic syndromes relapsed/refractory to erythropoiesis stimulating agents in imerge phase 3 |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428232/ http://dx.doi.org/10.1097/01.HS9.0000967572.05685.92 |
| work_keys_str_mv | AT platzbeckeruwe s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT santinivaleria s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT fenauxpierre s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT sekeresmikkael s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT savonamichaelrobert s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT madanatyazan s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT diezcampelomaria s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT valcarceldavid s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT illmerthomas s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT jonasovaanna s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT belohlavkovapetra s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT shermanlaurie s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT berrytymara s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT doughertysouria s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT shahsheetal s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT xiaqi s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT penglixian s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT sunlibo s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT wanying s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT huangfei s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT ikinannat s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT navadashyamala s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT komrokjiramis s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 AT zeidanamerm s165continuoustranfusionindependencewithimetelstatinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrelapsedrefractorytoerythropoiesisstimulatingagentsinimergephase3 |